Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Epilepsy × Immunoglobulins, Intravenous × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urologic Neoplasms 1 Neoplasms 1 Myasthenia Gravis 1 Melanoma 1 Limbic Encephalitis 1 Hematologic Neoplasms 1 Epilepsy 1 Epilepsies, Partial 1 Drug Resistant Epilepsy 1 Colonic Neoplasms 1 Autoimmune Diseases of the Nervous System 1 Autoimmune Diseases 1

Interventions

Everolimus 2 Sirolimus 1 Medical Marijuana 1 Immunoglobulins, Intravenous 1 Aspirin 1 Anticonvulsants 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01545518 2014-09-01

IVIG Treatment for Refractory Immune-Related Adult Epilepsy

Emory University

Phase 2 Terminated

20 enrolled 3 charts

Drug Resistant Epilepsy, Autoimmune Diseases, Epilepsy, Epilepsies, Partial, Autoimmune Diseases of the Nervous System, Limbic Encephalitis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡